
Immunologic treatment strategies in mantle cell lymphoma: checkpoint inhibitors, chimeric antigen receptor (CAR) T-cells, and bispecific T-cell engager (BiTE) molecules
Author(s) -
Joshua C. Pritchett,
Stephen M. Ansell
Publication year - 2019
Publication title -
annals of lymphoma
Language(s) - English
Resource type - Journals
ISSN - 2616-2695
DOI - 10.21037/aol.2019.05.01
Subject(s) - chimeric antigen receptor , mantle cell lymphoma , cancer research , cytotoxic t cell , medicine , antigen , lymphoma , t cell , immune checkpoint , immunology , immunotherapy , immune system , biology , in vitro , biochemistry